Cargando…

Flow Cytometric Assessment of Endothelial and Platelet Microparticles in Patients With Atrial Fibrillation Treated With Dabigatran

The prothrombotic state in patients with atrial fibrillation (AF) is related to endothelial injury, the activation of platelets and the coagulation cascade. We evaluated the levels of platelet- (CD42b) and endothelial-derived (CD144) microparticles in the plasma patients with non-valvular AF treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lenart-Migdalska, Aleksandra, Drabik, Leszek, Kaźnica-Wiatr, Magdalena, Tomkiewicz-Pająk, Lidia, Podolec, Piotr, Olszowska, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787695/ https://www.ncbi.nlm.nih.gov/pubmed/33237804 http://dx.doi.org/10.1177/1076029620972467

Ejemplares similares

Increased Levels of Platelets and Endothelial-Derived Microparticles in Patients With Non-Valvular Atrial Fibrillation During Rivaroxaban Therapy
por: Lenart-Migdalska, Aleksandra, et al.
Publicado: (2021)

Is it worth closing the atrial septal defect in patients with insignificant shunt?
por: Komar, Monika, et al.
Publicado: (2014)

Elevated level of plasma endothelin-1 in patients with atrial septal defect
por: Komar, Monika, et al.
Publicado: (2014)

Assessment of left ventricle function in aortic stenosis: mitral annular plane systolic excursion is not inferior to speckle tracking echocardiography derived global longitudinal peak strain
por: Luszczak, Joanna, et al.
Publicado: (2013)

Arterial stiffness in adult patients after Fontan procedure
por: Tomkiewicz-Pajak, Lidia, et al.
Publicado: (2014)

Quality of life in adults with repaired tetralogy of Fallot
por: Dłużniewska, Natalia, et al.
Publicado: (2018)

Cost of dabigatran for atrial fibrillation
por: Gage, Brian F
Publicado: (2011)

Long-Term Effects of Percutaneous Fenestration Following the Fontan Procedure in Adult Patients with Congenital Univentricular Heart
por: Smaś-Suska, Monika, et al.
Publicado: (2018)

Influence of chronic inflammation and autoimmunity on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients
por: Plazak, Wojciech, et al.
Publicado: (2011)

Long-term follow-up in adults after tetralogy of Fallot repair
por: Dłużniewska, Natalia, et al.
Publicado: (2018)

Transcranial doppler ultrasonography should it be the first choice for persistent foramen ovale screening?
por: Komar, Monika, et al.
Publicado: (2014)

Heart Rate Variability and Its Associations with Organ Complications in Adults after Fontan Operation
por: Okólska, Magdalena, et al.
Publicado: (2021)

Long-term observation of adults after successful repair of aortic coarctation
por: Róg, Beata, et al.
Publicado: (2019)

Twelve-Lead ECG, Holter Monitoring Parameters, and Genetic Testing in Brugada Syndrome: Insights from Analysis of Multigenerational Family with a History of Sudden Cardiac Arrest during Physical Activity
por: Matusik, Paweł T., et al.
Publicado: (2023)

Neutrophil-activating Peptide 2 as a Novel Modulator of Fibrin Clot Properties in Patients with Atrial Fibrillation
por: Ząbczyk, Michał, et al.
Publicado: (2023)

Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management
por: Weltermann, A., et al.
Publicado: (2012)

Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study
por: Plazak, Wojciech, et al.
Publicado: (2011)

Effect of ventricular function and volumes on exercise capacity in adults with repaired Tetralogy of Fallot
por: Dłużniewska, Natalia, et al.
Publicado: (2018)

Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation
por: Stöllberger, Claudia, et al.
Publicado: (2012)

Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation
por: Huber, K, et al.
Publicado: (2013)

Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
por: Benamer, Sufyan, et al.
Publicado: (2016)

Comparative Effectiveness and Safety of Dabigatran and Rivaroxaban in Atrial Fibrillation Patients
por: Lai, Chao‐Lun, et al.
Publicado: (2017)

Massive Left Atrial Thrombi during Dabigatran Therapy for Nonvalvular Atrial Fibrillation
por: Bachvarova, Velislava, et al.
Publicado: (2017)

Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
por: Undas, Anetta, et al.
Publicado: (2020)

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation
por: Choi, Jiyoon C, et al.
Publicado: (2014)

The clinical efficacy of dabigatran etexilate for preventing stroke in atrial fibrillation patients
por: Ellis, Christopher R, et al.
Publicado: (2013)

Effects of uninterrupted dabigatran on the intensity of anticoagulation during atrial fibrillation ablation
por: Osawa, Takumi, et al.
Publicado: (2021)

Thromboembolic Complications in Adult Patients Following Fontan Procedure—A Multicenter Study
por: Skubera, Maciej, et al.
Publicado: (2023)

Markers of Thrombogenesis and Fibrinolysis and Their Relation to Inflammation and Endothelial Activation in Patients with Idiopathic Pulmonary Arterial Hypertension
por: Kopeć, Grzegorz, et al.
Publicado: (2013)

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study
por: Sørensen, Rikke, et al.
Publicado: (2013)

Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
por: Wisløff, Torbjørn, et al.
Publicado: (2014)

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Effectiveness and safety of dabigatran versus acenocoumarol in ‘real-world’ patients with atrial fibrillation
por: Korenstra, Jennie, et al.
Publicado: (2016)

Risk factors and prevention of dabigatran‐related gastrointestinal bleeding in patients with atrial fibrillation
por: Nantsupawat, Teerapat, et al.
Publicado: (2017)

Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
por: Chan, Yi‐Hsin, et al.
Publicado: (2018)

Uninterrupted dabigatran is safer than warfarin in patients undergoing ablation for atrial fibrillation
por: Spartalis, Michael, et al.
Publicado: (2017)

Dabigatran for left atrial thrombus
por: Morita, Sae, et al.
Publicado: (2013)

Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J-dabigatran surveillance
por: Inoue, Hiroshi, et al.
Publicado: (2016)

Altered profile of circulating microparticles in nonvalvular atrial fibrillation
por: Siwaponanan, Panjaree, et al.
Publicado: (2019)

Dabigatran Therapy Resulting in the Resolution of Rivaroxaban-resistant Left Atrial Appendage Thrombi in Patients with Atrial Fibrillation
por: Watanabe, Tetsuya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6dna7prb706hdib11lhfje3kq5